Patents expiring in 2034

US 8729039

Use of inhibitory oligonucleotides to treat autoimmune disease

The Regents of the University of California · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8729088

Toll-like receptor modulators and treatment of diseases

The Regents of the University of California · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8728724

Identification of micro-RNAs involved in neuromuscular synapse maintenance and regeneration

The Board of Regents of the University of Texas System · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8729119

Serotonin reuptake inhibitors

Theravance, Inc. · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8728472

Antibodies that bind selectively to P25 and uses therefor

The Board of Regents of the University of Texas System · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8728499

Dendritic macroporous hydrogels prepared by crystal templating

The Board of Regents of the University of Texas System · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8729305

Process for the preparation of and crystalline forms of optical enantiomers of modafinil

Teva Sante · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8729248

Sperm-specific cation channel, CATSPER2, and uses therefor

The Board of Regents of the University of Texas System · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8729115

Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases

CARDIOLYNX AG · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8729100

Method and composition for treating an alpha adrenoceptor-mediated condition

VANDA PHARMACEUTICALS INC. · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8729053

Nuclear factor kappa B pathway inhibitor composition and use of same

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8729081

Compositions and methods for treating alcohol use disorders, pain and other diseases

VM Discovery Inc. · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8729087

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8729047

Compositions for inhibiting redox-sensitive GTPases

The Board of Regents of the University of Texas System · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8729037

Method and medicament for inhibiting the expression of a given gene

Alnylam Pharmaceuticals, Inc. · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8729028

Noggin-derived peptide and use thereof

CAREGEN CO., LTD. · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8729027

Therapeutic agent for fibromyalgia containing etanercept

AXIS · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8728806

Methods and compositions related to Th-1 dendritic cells

The Board of Regents of the University of Texas System · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8728757

Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)

The Regents of the University of California · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8728532

Ischemia/reperfusion protection compositions and methods of using

Regents of the University of Minnesota · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8728526

Coacervate microparticles useful for the sustained release administration of therapeutic agents

The United States of America, Represented by Secretary of Department of Health and Human Services, NIH · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8728493

Polymer based compositions and conjugates of non-steroidal anti-inflammatory drugs

Nektar Therapeutics · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8728524

Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions

Anika Therapeutics S.r.l. · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8728488

Methods of inducing an immune response in a host by administering flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8728458

Combination anti-HIV vectors, targeting vectors, and methods of use

The Regents of the University of California · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8727775

Dimer acid-derived dimethacrylates and use in dental restorative compositions

The Regents of the University of Colorado, a Body Corporate · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8728447

Teeth-whitening gel

FAR EASTERN NEW CENTURY CORPORATION · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8729102

Bicyclic compound

Takeda Pharmaceutical Company Limited · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2014142182

Aqueous Liquid Composition Containing 2-Amino-3-(4-Bromobenzoyl)Phenylacetic Acid

BAUSCH & LOMB [US] · Granted Thu May 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2890920

DERIVES DE 1,3-DIHYDROIMIDAZOLE-2-THIONE UTILISABLES DANS LE TRAITEMENT DE L'HYPERTENSION ARTERIELLE PULMONAIRE ET DES LESIONS PULMONAIRES

BIAL PORTELA & Cª S A [PT] · Granted Thu May 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3169263

AGENTS DE TRAITEMENT DE MALADIES CANCEREUSES EXPRIMANT CLAUDINE

TRON TRANSLATIONALALE ONKOLOGIE AN DER UNIV DER JOHANNES GUTENBERG UNIV MAINZ GEMENNUTZIGE GMBH [DE] · Granted Thu May 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8734786

Use of ECDI-fixed cell tolerance as a method for preventing allograft rejection

Northwestern University · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735593

Aminopyridines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735625

Dual-acting antihypertensive agents

Theravance, Inc. · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735538

Use of methanobactin

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735440

Methods for treating amyotrophic lateral sclerosis using pro-neurogenic compounds

The Board of Regents of the University of Texas System · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735452

Treating patients with intravenous ibuprofen

Cumberland Pharmaceuticals Inc. · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735408

Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate

LEXICON PHARMACEUTICALS, INC. · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735418

Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

Rigel Pharmaceuticals, Inc. · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735401

Thienopyrimidine compounds and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735400

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735126

Disease control with tick phospholipase A2

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735407

Purine derivatives as A3 adenosine receptor-selective agonists

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735369

Compositions and methods for inhibiting expression of a gene from the Ebola virus

The United States of America as represented by the Secretary of the Army · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735358

Methods for treating cancer by regulation of tumor necrosis factor-alpha

The Regents of the University of Colorado, a Body Corporate · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735382

Infusion and injection solution of levodopa

Dizlin Medical Design AB · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735392

Crystalline (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt

BIOMARIN PHARMACEUTICAL INC. · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8735355

Methods of use of fragments of secreted frizzled related protein, sFRP

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)